BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21557277)

  • 1. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
    Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
    Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
    Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
    PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.
    Fan X; Shangguan L; Li M; Li CY; Liu B
    Br J Dermatol; 2010 Aug; 163(2):340-4. PubMed ID: 20394629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
    Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
    Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
    Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
    Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
    Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China.
    Wang M; Wu D; Tan M; Gong W; Xue H; Shen H; Zhang Z
    Biochem Genet; 2009 Aug; 47(7-8):559-68. PubMed ID: 19565204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
    Wang J; Gao J; Li Y; Zhao X; Gao W; Peng L; Yan D; Liu L; Li D; Wei L; Qi J; Zhou C
    Gene; 2013 Jul; 524(2):193-6. PubMed ID: 23618817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.
    Moudi B; Salimi S; Farajian Mashhadi F; Sandoughi M; Zakeri Z
    ScientificWorldJournal; 2013; 2013():176741. PubMed ID: 24348139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
    Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y
    Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
    Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
    Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
    Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
    Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer.
    Kang S; Dong SM; Seo SS; Kim JW; Park SY
    Cancer Genet Cytogenet; 2008 Jan; 180(1):1-5. PubMed ID: 18068525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.